WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s share price gapped down prior to trading on Friday. The stock had previously closed at $11.08, but opened at $10.0501. WuXi Biologics (Cayman) shares last traded at $10.50, with a volume of 1,207 shares traded.
Analysts Set New Price Targets
Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One analyst has rated the stock with a Hold rating. According to data from MarketBeat, the stock currently has an average rating of “Hold”.
Get Our Latest Stock Report on WXXWY
WuXi Biologics (Cayman) Stock Down 7.7%
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) Inc. is a contract research, development and manufacturing organization focused on biologic medicines. Founded in 2010, the company provides services to biotechnology and pharmaceutical companies developing treatments for patients worldwide. Its services span the biologics development process, including discovery, cell-line and process development, analytical testing, and clinical and commercial manufacturing. The company works with products such as monoclonal and multispecific antibodies, recombinant proteins, and antibody-drug conjugates.
See Also
- Five stocks we like better than WuXi Biologics (Cayman)
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
